Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas Groot Koerkamp

Showing results (221-230 of 486) with videos related to

Pageof 49
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 29, 2020
Quality and performance of validated prognostic models for survival after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysisStefan Büttner, Boris Galjart, Berend R Beumer, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 30, 2017
The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinomaJeroen L A van Vugt, Marcia P Gaspersz, Robert J S Coelen, et al.
Surgery|July 25, 2024
Late cholangitis after pancreatoduodenectomy: A common complication with or without anatomical biliary obstructionAnne Claire Henry, Youcef Salaheddine, Jessica J Holster, et al.
Frontiers in Oncology|March 17, 2022
High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal AdenocarcinomaMohammad Hosein Aziz, Jelle C van Dongen, Lawlaw Saida, et al.
Annals of Surgical Oncology|June 5, 2020
A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional AnalysisDiamantis I Tsilimigras, J Madison Hyer, Anghela Z Paredes, et al.
Annals of Surgical Oncology|March 22, 2025
Recurrence-Free Survival as a Surrogate for Overall Survival Among Patients with Intrahepatic Cholangiocarcinoma Following Upfront Surgery: An International Multi-institutional AnalysisJun Kawashima, Yutaka Endo, Selamawit Woldesenbet, et al.
Annals of Surgical Oncology|March 11, 2025
ASO Visual Abstract: The Influence of Tumor Burden Score and Lymph Node Metastasis on the Survival Benefit of Adjuvant Chemotherapy in Intrahepatic CholangiocarcinomaJun Kawashima, Yutaka Endo, Selamawit Woldesenbet, et al.
Hepatology (Baltimore, Md.)|October 31, 2025
Satellite lesions versus intrahepatic metastasis in multifocal intrahepatic cholangiocarcinoma: Prognostic impact and genomic profilingTao Wei, Zhi-Jie Ma, Shouliang Guo, et al.
Annals of Surgical Oncology|May 19, 2025
ASO Visual Abstract: Recurrence-Free Survival as a Surrogate for Overall Survival among Patients with Intrahepatic Cholangiocarcinoma following Upfront Surgery-An International Multi-Institutional AnalysisJun Kawashima, Yutaka Endo, Selamawit Woldesenbet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX - The LAPC-2 trialFreek R van 't Land, Diba Latifi, Miranda Moskie, et al.
Pageof 49

Showing results (221-230 of 486) with videos related to

Sort By:
Pageof 49
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 29, 2020
Quality and performance of validated prognostic models for survival after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysisStefan Büttner, Boris Galjart, Berend R Beumer, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 30, 2017
The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinomaJeroen L A van Vugt, Marcia P Gaspersz, Robert J S Coelen, et al.
Surgery|July 25, 2024
Late cholangitis after pancreatoduodenectomy: A common complication with or without anatomical biliary obstructionAnne Claire Henry, Youcef Salaheddine, Jessica J Holster, et al.
Frontiers in Oncology|March 17, 2022
High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal AdenocarcinomaMohammad Hosein Aziz, Jelle C van Dongen, Lawlaw Saida, et al.
Annals of Surgical Oncology|June 5, 2020
A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional AnalysisDiamantis I Tsilimigras, J Madison Hyer, Anghela Z Paredes, et al.
Annals of Surgical Oncology|March 22, 2025
Recurrence-Free Survival as a Surrogate for Overall Survival Among Patients with Intrahepatic Cholangiocarcinoma Following Upfront Surgery: An International Multi-institutional AnalysisJun Kawashima, Yutaka Endo, Selamawit Woldesenbet, et al.
Annals of Surgical Oncology|March 11, 2025
ASO Visual Abstract: The Influence of Tumor Burden Score and Lymph Node Metastasis on the Survival Benefit of Adjuvant Chemotherapy in Intrahepatic CholangiocarcinomaJun Kawashima, Yutaka Endo, Selamawit Woldesenbet, et al.
Hepatology (Baltimore, Md.)|October 31, 2025
Satellite lesions versus intrahepatic metastasis in multifocal intrahepatic cholangiocarcinoma: Prognostic impact and genomic profilingTao Wei, Zhi-Jie Ma, Shouliang Guo, et al.
Annals of Surgical Oncology|May 19, 2025
ASO Visual Abstract: Recurrence-Free Survival as a Surrogate for Overall Survival among Patients with Intrahepatic Cholangiocarcinoma following Upfront Surgery-An International Multi-Institutional AnalysisJun Kawashima, Yutaka Endo, Selamawit Woldesenbet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX - The LAPC-2 trialFreek R van 't Land, Diba Latifi, Miranda Moskie, et al.
Pageof 49